Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, a minor metadata change with no visible impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T07:29:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Expanded the study's Locations section with a wide array of new sites across multiple countries and regions (examples include Argentina, Australia, Belgium, Brazil, Canada, China, France, Germany, Greece, Japan, Mexico, the Netherlands, Spain, the United Kingdom, and the United States).
    Difference
    3%
    Check dated 2025-12-18T22:28:24.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Non-significant editorial updates were made: the page now explains that publications are automatically filled from PubMed and the revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-27T07:57:00.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Deleted the generic government funding operating status notice from the page. The study content, eligibility criteria, and contacts remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-19T22:16:24.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The Locations section now lists 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 73657', replacing 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 73657'.
    Difference
    0.0%
    Check dated 2025-11-12T18:50:25.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the Study Details page for NCT04194944 LIBRETTO-431; core content such as the Study Title, design, interventions, primary and secondary outcomes, eligibility criteria, and Locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-29T10:10:01.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.